Adrian Adams's Trading History
| TLPHTalphera | Jun 24, 2026 | Director | Uninformative Buy | ― | $23.39K | |
| AKBAAkebia Therapeutics | Jun 22, 2026 | Director | Uninformative Buy | ― | $166.76K | |
| IMPLQImpel Pharmaceuticals | Aug 19, 2021 | ― | Informative Buy | 279.66K | $300.00 | |
| ARLZQAralez Pharmaceuticals | May 12, 2017 | ― | Uninformative Buy | ― | $7.14K | |
| AUXLAuxilium | Jan 30, 2015 | ― | Uninformative Sell | 4.39M | ― | |
| NBIXNeurocrine | ― | Director | ― | $0.00 |
You May Also Like
Adrian Adams insider profile FAQ
What is the percentage of profitable transactions made by Adrian Adams?
The percentage of profitable transactions made by Adrian Adams is 0%.
What is the average return per transaction made by Adrian Adams?
The average return per transaction made by Adrian Adams is -22.10%.
What stocks does Adrian Adams hold?
Adrian Adams holds: TLPH, AKBA, ARLZQ, IMPLQ, AUXL, NBIX stocks.
What was Adrian Adams's most profitable transaction?
Adrian Adams’s most profitable transaction was an Informative Sell of TLPH stock on June 15, 2020. The return on the trade was -4.50%.
What is Adrian Adams's role in Talphera?
Adrian Adams's role in Talphera is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.